Jan De Witte - Jan 18, 2023 Form 4 Insider Report for INTEGRA LIFESCIENCES HOLDINGS CORP (IART)

Role: President & CEO, Director
Signature: /s/ Eric Schwartz; Attorney-in-Fact
Stock symbol: IART
Transactions as of: Jan 18, 2023
Transactions value $: -$23,610
Form type: 4
Date filed: 1/19/2023, 03:17 PM
Previous filing: Nov 21, 2022
Next filing: Feb 15, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IART	Common Stock	Options Exercise	$0	+431		$0.00	431	Jan 18, 2023	Direct
transaction	IART	Common Stock	Tax liability	-$23.6K	-431	-100%	$54.78	0	Jan 18, 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IART	Restricted Stock Units	Options Exercise	$0	-431	-0.58%	$0.00	74K	Jan 18, 2023	Common Stock	431	$0.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The award was a restricted stock unit award which vests in three annual equal installments on the first, second and third anniversaries of the grant date of 1/18/2022 of which the first installment vested on 1/18/2023 and which shall be delivered to Mr. De Witte within 30 days following the first business day that occurs immediately following the six-month period after the date of his separation of service as deferred compensation.

Content

The award was a restricted stock unit award which vests in three annual equal installments on the first, second and third anniversaries of the grant date of 1/18/2022 of which the first installment vested on 1/18/2023 and which shall be delivered to Mr. De Witte within 30 days following the first business day that occurs immediately following the six-month period after the date of his separation of service as deferred compensation.